Annette M. May - Concepedia

Author

Annette M. May

University Medical Center Freiburg ORCID

Also Known As

A May, A. M. May, A. May, A.M. May, Annette M May, Annette M. May, Annette May

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Freiburg University of Freiburg German Cancer Research Center Heidelberg University RWTH Aachen University

About

Annette M. May is an author at University Medical Center Freiburg specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	1.1K
2	Cell Biology	3	3	49
3	Health Sciences	2	2	42
4	Engineering	1	1	10
5	Blood Transplantation	1	1	39

Annette M. May

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations Desirée Schubert, Claudia Bode, Rupert Kenefeck, Nature Medicine ImmunogeneticsAutoimmune DiseaseImmunodeficienciesGeneticsImmunology	2014	805
Cytogenetics of extramedullary manifestations in multiple myeloma Lisa Billecke, Eva Maria Murga Penas, Annette M. May, British Journal of Haematology	2013	99
Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib – A report of two cases Sarah K. Wendel, Nils Venhoff, B Frye, Journal of Autoimmunity Janus-kinase Inhibitor TofacitinibExtensive CalcificationsPathologyDermatologyMedicine	2019	93
T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency Manuella L. Gomes Ochtrop, Sigune Goldacker, Annette M. May, Blood	2011	90
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial Michael Lübbert, Olga Grishina, Claudia Schmoor, Journal of Clinical Oncology	2019	88
DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy Olga Grishina, Claudia Schmoor, Konstanze Döhner, BMC Cancer	2015	53
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years Monika Engelhardt, Gabriele Ihorst, Ola Landgren, Haematologica	2015	51
Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation Sebastian Sommer, Marjan Cruijsen, Rainer Claus, Leukemia Research Hematological MalignancyCell TherapyTransplantationMarrow TransplantationMedicine	2018	39
Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition Karl X. Knaup, Thomas Hackenbeck, Bernt Popp, Journal of the American Society of Nephrology	2018	35
Template‐based synoptic reports improve the quality of pathology reports of prostatectomy specimens Konrad Aumann, Dominic Amann, Vera Gumpp, Histopathology	2012	28

Page 1